Risk factor analysis for adverse events and stent dysfunction of endoscopic ultrasound-guided choledochoduodenostomy
- PMID: 31883405
- DOI: 10.1111/den.13620
Risk factor analysis for adverse events and stent dysfunction of endoscopic ultrasound-guided choledochoduodenostomy
Abstract
Background and aims: Although the technique of endoscopic ultrasound-guided choledochoduodenostomy (EUS-CDS) is becoming standardized, its safety issues have not been sufficiently investigated. Therefore, we aimed to identify factors associated with adverse events and stent patency in EUS-CDS.
Methods: Consecutive patients who underwent EUS-CDS between September 2003 and July 2017 were included. Technical/clinical success, adverse events and stent dysfunctions were analyzed retrospectively.
Results: A total of 151 patients underwent EUS-CDS. In nine patients, procedures were discontinued before puncture. Technical and clinical success rates were 96.5% (137/142) and 98.5% (135/137), respectively. The adverse event rate was 20.4% (29/142). As a risk factor for peritonitis, plastic stents (PS) showed a significantly high odds ratio (OR) compared with covered self-expandable metal stents (CSEMS; OR, 4.31; P = 0.030). CSEMS cases showed a significantly longer patency period than PS cases (329 vs 89 days; HR, 0.35; P < 0.001). As a risk factor for early stent dysfunction (within 14 days), stent direction to the oral side showed a significantly high OR (OR, 43.47; P < 0.001). In cases with oblique-viewing EUS, double penetration of the duodenum occurred at significantly higher frequency than in cases with forward-viewing EUS (7.0 vs 0.0%; P = 0.024).
Conclusions: Plastic stents and stent direction to the oral side were risk factors for peritonitis and early stent dysfunction, respectively. Using covered self-expandable metal stents and changing stent direction to the anal side seemed appropriate to prevent peritonitis and early stent dysfunction.
Keywords: adverse event; endoscopic ultrasound-guided choledochoduodenostomy; obstructive jaundice; risk factor; stent dysfunction.
© 2019 Japan Gastroenterological Endoscopy Society.
References
-
- Moss AC, Morris E, Mac Mathuna P. Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane Database Syst. Rev. 2006; Cd004200.
-
- Inamdar S, Slattery E, Bhalla R et al. Comparison of adverse events for endoscopic vs percutaneous biliary drainage in the treatment of malignant biliary tract obstruction in an inpatient national cohort. JAMA Oncol. 2016; 2: 112-7.
-
- Tse F, Yuan Y, Moayyedi P et al. Guide wire-assisted cannulation for the prevention of post-ERCP pancreatitis: A systematic review and meta-analysis. Endoscopy 2013; 45: 605-18.
-
- Yamauchi H, Kida M, Imaizumi H et al. Innovations and techniques for balloon-enteroscope-assisted endoscopic retrograde cholangiopancreatography in patients with altered gastrointestinal anatomy. World J. Gastroenterol. 2015; 21: 6460-9.
-
- Wang K, Zhu J, Xing L et al. Assessment of efficacy and safety of EUS-guided biliary drainage: A systematic review. Gastrointest. Endosc. 2016; 83: 1218-27.
MeSH terms
LinkOut - more resources
Full Text Sources